Precursors to pancreatic cancer
- PMID: 17996793
- PMCID: PMC2194627
- DOI: 10.1016/j.gtc.2007.08.012
Precursors to pancreatic cancer
Abstract
Infiltrating ductal adenocarcinoma of the pancreas is believed to arise from morphologically distinct noninvasive precursor lesions. These precursors include the intraductal papillary mucinous neoplasm, the mucinous cystic neoplasm, and pancreatic intraepithelial neoplasia. Intraductal papillary mucinous neoplasms are grossly visible mucin-producing epithelial neoplasms that arise in the main pancreatic duct or one of its branches. The cysts of mucinous cystic neoplasms do not communicate with the major pancreatic ducts, and these neoplasms are characterized by a distinct ovarian-type stroma. Pancreatic intraepithelial neoplasia is a microscopic lesion. This article focuses on the clinical significance of these three important precursor lesions, with emphasis on their clinical manifestations, detection, and treatment.
Figures









Similar articles
-
Clinical importance of precursor lesions in the pancreas.J Hepatobiliary Pancreat Surg. 2007;14(3):255-63. doi: 10.1007/s00534-006-1170-9. Epub 2007 May 29. J Hepatobiliary Pancreat Surg. 2007. PMID: 17520200 Review.
-
Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.Pancreatology. 2007;7(1):9-19. doi: 10.1159/000101873. Epub 2007 Apr 18. Pancreatology. 2007. PMID: 17449961 Review.
-
Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.Mod Pathol. 2005 Aug;18(8):1034-42. doi: 10.1038/modpathol.3800383. Mod Pathol. 2005. PMID: 15832194
-
Cystic lesions of the pancreas.Mod Pathol. 2007 Feb;20 Suppl 1:S71-93. doi: 10.1038/modpathol.3800706. Mod Pathol. 2007. PMID: 17486054
-
Current understanding of precursors to pancreatic cancer.J Hepatobiliary Pancreat Surg. 2007;14(3):217-23. doi: 10.1007/s00534-006-1165-6. Epub 2007 May 29. J Hepatobiliary Pancreat Surg. 2007. PMID: 17520195 Review.
Cited by
-
Risk of additional pancreatic cancer in patients with branch duct intraductal papillary-mucinous neoplasm.Clin J Gastroenterol. 2009 Dec;2(6):365-370. doi: 10.1007/s12328-009-0116-6. Epub 2009 Oct 30. Clin J Gastroenterol. 2009. PMID: 26192788
-
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.World J Gastroenterol. 2014 Aug 28;20(32):11182-98. doi: 10.3748/wjg.v20.i32.11182. World J Gastroenterol. 2014. PMID: 25170203 Free PMC article. Review.
-
Aberrant signaling pathways in pancreatic cancer: a two compartment view.Mol Carcinog. 2012 Jan;51(1):25-39. doi: 10.1002/mc.20827. Mol Carcinog. 2012. PMID: 22162229 Free PMC article.
-
Overweight increases the risk of malignancy in patients with pancreatic mucinous cystic neoplasms.Medicine (Baltimore). 2015 May;94(20):e797. doi: 10.1097/MD.0000000000000797. Medicine (Baltimore). 2015. PMID: 25997051 Free PMC article.
-
MicroRNAs in pancreatic ductal adenocarcinoma.World J Gastroenterol. 2011 Feb 21;17(7):817-27. doi: 10.3748/wjg.v17.i7.817. World J Gastroenterol. 2011. PMID: 21412491 Free PMC article.
References
-
- American Cancer Society. Cancer. New York: New York, American Cancer Society; 2007. Cancer Facts & Figures 2007; pp. 1–52.
-
- Hruban RH, Pitman MB, Klimstra DS. Atlas of tumor pathology. Fascicle 6. Washington, DC: American Registry of Pathology and Armed Forces Institute of Pathology; 2007. Tumors of the pancreas. (Fourth).
-
- Hulst SPL. Zur kenntnis der Genese des Adenokarzinoms und Karzinoms des Pankreas. Virchows Arch (B) 1905;180:288–316.
-
- Hruban RH, Goggins M, Parsons JL, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res. 2000;6:2969–2972. - PubMed
-
- Brat DJ, Lillemoe KD, Yeo CJ, Warfield PB, Hruban RH. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol. 1998;22(2):163–169. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical